Effective cancer immunotherapy is often thwarted by physical barriers and signaling failure. We demonstrate that elevated interstitial fluid pressure (IFP) in "cold" tumors creates a phicscal exclusion zone, preventing T-cell infiltration, While lymphatic hypertension triggers valve occlusion, the tumor microenvironment effectively loses systemic immunity. To address these challenges, we developed two synergistic protocols: Fever Simulation (FSP) and Lymphatic Pressure Balance Entry (LPBE). FSP reconfigures the biophysical environment by modulating tumor thermomechanics to reduce IFP, successfully converting cold tumors into "hot" immune-active sites. Simultaneously, LPBE restores lymphatic patency by balancing nodal pressure, re-establishing the essential conduit for tumor-derived antigens and immune cell trafficking. Integration of FSP and LPBE not only bypasses the Physical resistance of the tumor stroma but also reactivates the systemic immune response. This dual-action framework provides a biophysical paradigm shift, offering a programmable pathway to overcome terminal-stage immune evasion and achieve systemic tumor regression. "Conclusion: Toward a Controllable Paradigm of Oncology" By acknowledging the thermodynamic and hydrodynamic barriers of the tumor microenvironment, we transform spontaneous regression from a rare mystery into a reproducible engineering outcome. FSP and LPBE are not merely supplementary treatments but are fundamental requirements for restoring the systemic "flow" of the immune system.
Li Chung Lee (Wed,) studied this question.